Dergiler / European journal of geriatrics and gerontology (Online) / 2022 / Cilt: 4 - Sayı: 2

Overview of COVID-19 Vaccine and Investigation of Side Effects in Patients Over 65 Years of Age with Chronic Kidney Disease

Sayfa
91–96
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In addition, although the frequency of side effects was lower in our study population, uncontrolled blood pressure was observed differently and it was observed that the presence of cardiovascular disease increased the frequency of side effects.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: The entire population should be vaccinated to prevent the spread of Coronavirus disease-2019 (COVID-19).
📊
Temel Bulgular & Veri:In this study, we aimed to evaluate the acceptance of the COVID-19 vaccine and the frequency of side effects in patients over 65 years of age with chronic renal failure.
💡
Sonuç & Katkı:In addition, although the frequency of side effects was lower in our study population, uncontrolled blood pressure was observed differently and it was observed that the presence of cardiovascular disease increased the frequency of side effects.
🔬Tür:Araştırma Makalesi
📍Kapsam:2019 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: The entire population should be vaccinated to prevent the spread of Coronavirus disease-2019 (COVID-19). In this study, we aimed to evaluate the acceptance of the COVID-19 vaccine and the frequency of side effects in patients over 65 years of age with chronic renal failure. Materials and Methods: Patients with chronic renal failure over the age of 65 who applied to the nephrology outpatient clinic between 14.03.2021 and 15.04.2021 were included. Demographic characteristics, comorbidities, whether they were vaccinated, and post-vaccination symptoms were recorded. Results: In our study, 112 patients with chronic renal failure were evaluated. 94% of the patients (105/12) reported a positive opinion about the vaccine. The most common cause of COVID-19 vaccine opposition was related to vaccine side effects (54%). Of the patients included in the study, 89 were vaccinated with CoronaVac. Side effects were seen in 23% of patients after at least one dose of CoronaVac. The most common side effects were uncontrolled blood pressure and pain at the injection site. In patients reporting adverse events after at least one dose of CoronaVac and 1st dose of vaccine; coronary vascular diseases (CVD) was significantly higher (p=0.012, p=0.001), patients receiving hemodialysis treatment had fewer adverse events (p=0.005, p=0.032), and injection site pain was more common in female patients (p=0.023, p=0.023). The most common adverse event after the 2nd dose was uncontrolled blood pressure and was significantly higher in female patients (p=0.023, p=0.001). Conclusion: Although the rate of vaccination against COVID-19 is high in individuals over 65 years of age with chronic kidney disease, the most common reason for vaccine opposition was vaccine side effects. In addition, although the frequency of side effects was lower in our study population, uncontrolled blood pressure was observed differently and it was observed that the presence of cardiovascular disease increased the frequency of side effects.

🔖

Bu Makaleye Atıf Yap

BAHAT, K. A. (2022). Overview of COVID-19 Vaccine and Investigation of Side Effects in Patients Over 65 Years of Age with Chronic Kidney Disease. European journal of geriatrics and gerontology (Online), Cilt: 4 - Sayı: 2, 91–96. https://ajindex.com/articles/511193

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Henry MB, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int Urol Nephrol 2020;52:1193-1194
  2. Wang J, Jing R, Lai X, Zhang H, Lyu Y, Knoll M.D, Fang H. Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China. Vaccines (Basel) 2020;8:482
  3. Luo H, Qu H, Basu R, Rafferty AP, Patil SP, Cummings DM. Willingness to Get a COVID-19 Vaccine and Reasons for Hesitancy Among Medicare Beneficiaries: Results From a National Survey. J Public Health Manag Pract 2022;28:70-76
  4. Zewude B, Habtegiorgis T. Willingness to Take COVID-19 Vaccine Among People Most at Risk of Exposure in Southern Ethiopia. Pragmat Obs Res 2021;12:37-47
  5. Vaziri ND, Pahl MV, Crum A, Norris K. Effect of uremia on structure and function of immune system. J Ren Nutr 2012;22:149-156
  6. Udomkarnjananun S, Takkavatakarn K, Praditpornsilpa K, Nader C, Eiam- Ong S, Jaber BL, Susantitaphong P. Hepatitis B virus vaccine immune response and mortality in dialysis patients: a meta-analysis. J Nephrol 2020;33:343-354
  7. Jęśkowiak I, Wiatrak B, Grosman-Dziewiszek P, Szeląg A. The Incidence and Severity of Post-Vaccination Reactions after Vaccination against COVID-19. Vaccines (Basel) 2021;9:502
  8. Riad A, Pokorná A, Attia S, Klugarová J, Koščík M, Klugar M. Prevalence of COVID-19 Vaccine Side Effects among Healthcare Workers in the Czech Republic. J Clin Med 2021;10:1428
  9. Bono SA, Faria de Moura Villela E, Siau CS, Chen WS, Pengpid S, Hasan MT, Sessou P, Ditekemena JD, Amodan BO, Hosseinipour MC, Dolo H, Siewe Fodjo JN, Low WY, Colebunders R. Factors Affecting COVID-19 Vaccine Acceptance: An International Survey among Low- and Middle-Income Countries. Vaccines (Basel) 2021;9:515
  10. Malesza M, Wittmann E. Acceptance and Intake of COVID-19 Vaccines among Older Germans. J Clin Med 2021;10:1388
  11. Garcia P, Montez-Rath ME, Moore H, Flotte J, Fults C, Blok MS, Han J, Dittrich M, Parsonnet J, Chertow GM, Blok GA, Anand S. SARS-CoV-2 Vaccine Acceptability in Patients on Hemodialysis: A Nationwide Survey. J Am Soc Nephr 2021;32:1575-1581
  12. Kaya F, Pirincci E. Determining the frequency of serious adverse reactions of inactive SARS-COV-2 vaccine. Work 2021;69:735-739
  13. Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I. Disturbances of acquired immunity in hemodialysis patients. Semin Dial 2007;20:440-451
  14. Meo SA, Bukhari IA, Akram J, Meo AS, Klonoff DC. COVID-19 vaccines: comparison of biological, p